Description
MOTS-c 10mg — mitochondrial-derived peptide for metabolic research in Australia. University-verified ≥99% purity. Same-day Sydney dispatch.
MOTS-c (Mitochondrial ORF of the 12S rRNA type-c) is a 16-amino acid peptide encoded within mitochondrial DNA, first described in 2015 by the Cohen laboratory at USC. It represents one of the few known peptides encoded by mitochondrial rather than nuclear DNA.
What the Research Shows
Research has examined MOTS-c’s effects on AMPK activation, a master regulator of cellular energy metabolism. Studies demonstrate its influence on glucose uptake, fatty acid oxidation, and metabolic homeostasis.
Additional research explores MOTS-c as an exercise-mimetic and its age-related changes. The peptide opens a new field of research into mitochondrial-derived peptides as metabolic signalling molecules.
Why Australian Researchers Choose Purpose Labs
Every batch is tested at a leading Australian university — HPLC and mass spectrometry confirm ≥99% purity. No generic overseas certificates.
Note: MOTS-c may be less stable than many peptides — minimise time outside refrigeration during handling.
Purity: ≥99% (HPLC)
Form: Lyophilised powder
Molecular Weight: 2174.68 Da
CAS: 1627580-64-6
Sequence: MRWQEMGYIFYPRKLR
Research: PubMed
▸ Australian university verified
▸ ≥99% purity guaranteed
▸ Same-day dispatch from Sydney
▸ Research-grade lyophilised powder
Related Research and Resources
For research use only. Not for human consumption.




